These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


642 related items for PubMed ID: 28315622

  • 1. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL.
    JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622
    [Abstract] [Full Text] [Related]

  • 2. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.
    J Am Heart Assoc; 2018 Jun 13; 7(12):. PubMed ID: 29899017
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A, Massaro JM, D'Agostino RB, O'Donnell CJ, Hoffmann U.
    JAMA; 2015 Jul 14; 314(2):134-41. PubMed ID: 26172893
    [Abstract] [Full Text] [Related]

  • 5. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E.
    J Am Coll Cardiol; 2016 Aug 30; 68(9):881-91. PubMed ID: 27561760
    [Abstract] [Full Text] [Related]

  • 6. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb 30; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 7. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB, Nordestgaard BG.
    JAMA Cardiol; 2019 Nov 01; 4(11):1131-1138. PubMed ID: 31577339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
    Patel J, Pallazola VA, Dudum R, Greenland P, McEvoy JW, Blumenthal RS, Virani SS, Miedema MD, Shea S, Yeboah J, Abbate A, Hundley WG, Karger AB, Tsai MY, Sathiyakumar V, Ogunmoroti O, Cushman M, Savji N, Liu K, Nasir K, Blaha MJ, Martin SS, Al Rifai M.
    JAMA Cardiol; 2021 Oct 01; 6(10):1161-1170. PubMed ID: 34259820
    [Abstract] [Full Text] [Related]

  • 10. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S, Pollack S, Roth M, Reichek N, Guerci A, Cao JJ.
    Atherosclerosis; 2016 Dec 01; 255():193-199. PubMed ID: 27693004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y, O'Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, D'Agostino R, Newman AB, Nasir K, Hofman A, Lehmann N, Dhana K, Blankstein R, Hoffmann U, Möhlenkamp S, Massaro JM, Mahabadi AA, Lima JAC, Ikram MA, Jöckel KH, Franco OH, Liu K, Lloyd-Jones D, Greenland P.
    JAMA Cardiol; 2017 Sep 01; 2(9):986-994. PubMed ID: 28746709
    [Abstract] [Full Text] [Related]

  • 15. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Flueckiger P, Qureshi W, Michos ED, Blaha M, Burke G, Sandfort V, Herrington D, Yeboah J.
    Clin Cardiol; 2017 Mar 01; 40(3):163-169. PubMed ID: 27859433
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.
    JAMA; 2017 Apr 18; 317(15):1563-1567. PubMed ID: 28418481
    [Abstract] [Full Text] [Related]

  • 20. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC, Psaty BM, Greenland P, Herrington DM.
    Circulation; 2015 Sep 08; 132(10):916-22. PubMed ID: 26224808
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.